{"id":"W2622725967","doi":"10.1002/hon.2437_107","title":"COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Progressive disease; Gastroenterology; Rituximab; Lymphoma; Clinical endpoint; Refractory (planetary science); Phases of clinical research; Follicular lymphoma; Oncology; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000373972,0.0002808737,0.001015084,0.0001449312,0.0002005412,0.00003501516,0.0004907252,0.0005836358,0.0007081749],"category_scores_gemma":[0.001090852,0.0001658396,0.00008654912,0.000129817,0.0007189286,0.0001358583,0.0003641471,0.0004516655,0.0003817583],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01033016,"about_ca_system_score_gemma":0.006415494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002075861,"about_ca_topic_score_gemma":0.0001971127,"domain_scores_codex":[0.9973041,0.00018037,0.0005482129,0.000637455,0.0005530239,0.0007767985],"domain_scores_gemma":[0.9974999,0.0005275289,0.0003319356,0.001109128,0.0001699518,0.0003614874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06384883,0.02461236,0.8106879,0.001077578,0.0002284028,0.0280037,0.0008231425,0.000009191113,0.0002807797,0.001406423,0.01530144,0.05372029],"study_design_scores_gemma":[0.2321515,0.02098806,0.7052577,0.0004062823,0.00009768375,0.0009518988,0.000173898,0.0005035221,0.00129718,0.0001366723,0.03749312,0.0005425036],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726708,0.0001182805,0.00001666403,0.0007279583,0.0001728231,0.0009537963,0.000004605588,0.00006752027,0.02526755],"genre_scores_gemma":[0.996682,0.00007111719,0.001061109,0.0006438463,0.00007203804,0.0001103874,0.00002685277,0.00003406964,0.001298583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1683027,"threshold_uncertainty_score":0.9992172,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03686729126405178,"score_gpt":0.3419778960514678,"score_spread":0.305110604787416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}